Drug Type Autologous CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism PSMA modulators(Prostate-specific membrane antigen modulators), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Prostate Carcinoma | Phase 1 | China | 01 Mar 2023 | |
Advanced Prostate Carcinoma | Phase 1 | China | 01 Mar 2023 |